Background {#Sec1}
==========

Acute lung injury (ALI), also called acute respiratory distress syndrome (ARDS), is a systemic inflammatory response syndrome characterized by refractory hypoxemia and respiratory distress \[[@CR1]\]. It can be caused by all kinds of pathogenic factors inside and outside the lungs (such as serious infection, aspiration, sepsis, trauma and shock), principally sepsis \[[@CR1]-[@CR3]\]. ALI appears the earliest and is with the highest incidence in patients with sepsis \[[@CR4],[@CR5]\]. Although advancements in critical care has improved the survival among patients with ALI, the mortality is still as high as 40% and the rate of survivors with significant pulmonary impairment is approximately 50% \[[@CR6]\].

The major challenge is accurate and early diagnosis of patients with ALI. The current clinical criteria include pulmonary edema, hypoxemia and widespread capillary leakage. However, there's a discrepancy between clinical criteria and histological autopsy findings \[[@CR7]\]. Intraobserver variability in diagnosis is also unavoidable. Thus, the difficulties in diagnosis make it necessary to identify biomarkers for ALI. Many studies have been carried out in different sample sources like pulmonary edema \[[@CR8]\], fluid blood and urine \[[@CR9],[@CR10]\]. In addition, gene expression profiles analysis has been conducted, microarray technology enables a global investigation of gene expression and promotes identification of biomarkers of potential diagnostic and prognostic significance \[[@CR11]-[@CR13]\]. Moreover, it provides insights on the molecular mechanisms underlying the ALI \[[@CR14],[@CR15]\].

In 2009, Howrylak *et al.* used a gene expression microarray data to develop a gene signature of ARDS/ALI between patients with ALI + sepsis and patients with sepsis alone, and obtained an eight-gene expression profile that can distinguish patients with ALI + sepsis from patients with sepsis alone accurately \[[@CR11]\]. In 2013, Chen *et al.* downloaded the expression profile deposited by Howrylak *et al.* \[[@CR11]\], and identified the differentially expressed genes (DEGs) between patients with ALI + sepsis and patients with sepsis alone and obtained 12 DEGs. They also constructed protein-protein interaction network (PPI) and conducted functional enrichment analysis, and obtained two networks (OCLN and HLA-DQB1), as well as enriched 7 significant functions in OCLN network and 5 functions in HLA-DQB1 network \[[@CR16]\]. Using the same data by Howrylak *et al*. \[[@CR11]\], we aimed to further screen the DEGs. Especially, hierarchical clustering of genes and samples by the expression level of the DEGs was performed. And the potential functions of the DEGs were analyzed by Gene Ontology (GO) and pathway enrichment analyses. In addition, the interaction relationships between these DEGs significantly enriched in Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways were investigated by regulatory network.

Methods {#Sec2}
=======

Gene expression data {#Sec3}
--------------------

Expression profile of GSE10474 \[[@CR11]\] was downloaded from Gene Expression Omnibus database (GEO, <http://www.ncbi.nlm.nih.gov/geo/>), including 13 whole blood samples with ALI plus sepsis (ALI + sepsis) and 21 whole blood samples with sepsis alone. Patients admitted to the Medical Intensive Care Unit (MICU) of the University of Pittsburgh Medical Center for no more than 48 h who received mechanical ventilation were regarded suitable for the study. And appropriate patients were recruited from the MICU between February 2005 and June 2007. Gene expression was measured using Affymetrix Human Genome U133A 2.0 Array (Affymetrix Inc., Santa Clara, California, USA).

Pre-treatment and differential analysis {#Sec4}
---------------------------------------

Raw data were read with package affy of *R* \[[@CR17]\] in Bioconductor \[[@CR18]\]. Background correction, normalization and calculation of expression value were performed using the robust multichip averaging (RMA) method. Differential analysis was conducted using package Simpleaffy \[[@CR19]\] based upon t-test and fold change. The adjusted p-value \< 0.05 and \|log~2~fold-change (FC)\| \> 1 were set as the cut-off criteria.

Clustering analysis {#Sec5}
-------------------

As a widely used data analysis tool, hierarchical clustering is aimed to build a binary tree of the data that successively combines similar point groups, and visualization of the tree offers a useful summary of this data \[[@CR20]\]. Hierarchical clustering of genes and samples by the expression level of the DEGs was performed using hierarchical cluster function hclust from base package stats of *R* \[[@CR17]\].

Functional enrichment analysis {#Sec6}
------------------------------

To obtain an in-depth analysis of the DEGs from the functional levels, biological process (BP), cell components (CC) and molecular function (MF) functional enrichment analysis was conducted using iGepros \[[@CR21]\] (<http://www.biosino.org/iGepros/index.jsp>). P-value \< 0.05 was set as the cut-off to screen out significant GO terms and KEGG pathways. Significant KEGG pathways were visualized using KEGG Mapper tools \[[@CR22]\].

Gene regulatory network construction {#Sec7}
------------------------------------

A total of 27 DEGs were significantly enriched in 16 KEGG pathways. In addition, regulators of these DEGs and various regulatory relationships (such as activation, inhibition, phosphorylation, compound binding, coexpression, and protein-protein interaction) were retrieved from the 16 KEGG pathways. The gene regulatory network was visualized by Cytoscape \[[@CR23]\]. Proteins in the network served as the \'nodes\', and each pairwise protein interaction (referred to as edge) was represented by an undirected link. The property of the network was analyzed with the plug-in network analysis.

Results {#Sec8}
=======

Differentially expressed genes {#Sec9}
------------------------------

According to the criteria (adjusted p-value \< 0.05 and \|log~2~FC\| \> 1), a total of 128 DEGs were identified in patients with ALI + sepsis compared with patients with sepsis alone, including 47 up-regulated genes and 81 down-regulated genes.

Functional enrichment analysis results {#Sec10}
--------------------------------------

Top 10 GO terms (BP, CC and MF) are shown in Table [1](#Tab1){ref-type="table"}. Negative regulation of cell proliferation, regulation of response to stimulus and cellular component morphogenesis were included in the list.Table 1**Top 10 Gene Ontology (GO) terms enriched in the differentially expressed genesOntologyGO_IDP-valueCountTerm**BPGO:00082857.85E-0512negative regulation of cell proliferationGO:00325020.00011665247developmental processGO:00601610.0001601832positive regulation of dopamine receptor signaling pathwayGO:00400110.00019281819locomotionGO:00329890.00021613616cellular component morphogenesisGO:00487320.0002250858gland developmentGO:00072670.00023749718cell-cell signalingGO:00485830.00045181627regulation of response to stimulusGO:00009040.00050702613cell morphogenesis involved in differentiationGO:00181080.0005613656peptidyl-tyrosine phosphorylationCCGO:00055783.27E-0511proteinaceous extracellular matrixGO:00055767.15E-0530extracellular regionGO:00059380.00078896cell cortexGO:00056150.001135114extracellular spaceGO:00444200.00130326extracellular matrix partGO:00163230.00209777basolateral plasma membraneGO:00056240.005298913membrane fractionGO:00099860.0055488cell surfaceGO:00059010.00591763caveolaGO:00335930.00693531BRCA2-MAGE-D1 complexMFGO:00195340.00049392toxin transporter activityGO:00085040.00102762monoamine transmembrane transporter activityGO:00428030.001948810protein homodimerization activityGO:00301650.00230214PDZ domain bindingGO:00055150.002321555protein bindingGO:00052010.00264184extracellular matrix structural constituentGO:00081440.00276224drug bindingGO:00228040.00298778active transmembrane transporter activityGO:00151010.00371192organic cation transmembrane transporter activityGO:00507500.00431052low-density lipoprotein particle receptor bindingBP, biological process; CC, cellular component; MF, molecular function; Count, number of differentially expressed genes.

A total of 120 KEGG pathways were enriched for the 128 DEGs, including 16 significantly enriched pathways (Table [2](#Tab2){ref-type="table"}), such as fatty acid metabolism, beta-alanine metabolism, ErbB signaling pathway, ECM-receptor interaction, protein digestion and absorption, bile secretion and gastric acid secretion.Table 2**Significant Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways enriched in the differentially expressed genesKEGG_IDP-valueCountSizeTerm**K049740.0058969481Protein digestion and absorptionK000710.0066462343Fatty acid metabolismK051460.01492734106AmoebiasisK004100.0164577222beta-Alanine metabolismK049500.021009225Maturity onset diabetes of the youngK051000.0248666370Bacterial invasion of epithelial cellsK049760.0258013371Bile secretionK049710.0287182374Gastric acid secretionK053100.0296041230AsthmaK045140.03134844133Cell adhesion molecules (CAMs)K045100.03335515200Focal adhesionK000400.0333724232Pentose and glucuronate interconversionsK045120.0408489385ECM-receptor interactionK040120.0432936387ErbB signaling pathwayK053300.0435527237Allograft rejectionK052150.0458106389Prostate cancer

The regulatory network of the DEGs {#Sec11}
----------------------------------

A total of 27 DEGs were significantly enriched in 16 KEGG pathways. Regulators of these DEGs and various regulatory relationships (such as activation, inhibition, phosphorylation, compound binding, co-expression, and protein-protein interaction) were retrieved from the 16 KEGG pathways. The regulatory network was constructed (Figure [1](#Fig1){ref-type="fig"}). Especially, protein tyrosine kinase 2 (PTK2), v-src avian sarcoma (SRC), and Caveolin 2 (CAV2) may be hub genes for ALI. Furthermore, in the regulatory network of the DEGs, SRC had interaction relationships with PTK2, as well as CAV2 were targeted by SRC.Figure 1**The regulatory network of the differentially expressed gene.** The protein products of the DEGs are in red. The size of a node correlates with the number of interactions of the node while the thickness of an edge correlates with the edge betweenness of the edge.

Discussion {#Sec12}
==========

A total of 128 DEGs were identified in sepsis-induced ALI compared with sepsis, including 47 up-regulated genes and 81 down-regulated genes. Functional enrichment analysis indicated that several metabolism-related KEGG pathways were enriched in the DEGs, including fatty acid metabolism and beta-alanine metabolism. Several signaling pathways were also significantly enriched in the DEGs, such as ECM-receptor interaction and ErbB signaling pathway. Especially, the regulatory network of the 27 DEGs involved several key genes (such as PTK2, SRC and CAV2).

PTK2 and SRC both were implicated in cell growth and they were down-regulated in ALI \[[@CR24],[@CR25]\]. Since repair of damaged endothelium is important in recovery from ALI and increased circulating endothelial progenitor cells are associated with survival \[[@CR26]\], we speculated that modulation of these cell growth-related genes could provide another way to treat the disease. Besides, digestion-related pathways were also disclosed in the DEGs, such as protein digestion and absorption, bile secretion and gastric acid secretion, which might be explained by poor health of patients with ALI.

As an important family for intracellular signal transduction, Src protein tyrosine kinases (PTKs) are associated with acute inflammatory responses \[[@CR27]-[@CR30]\]. It's not expression level alteration of Src PTK but its activation may be related to reperfusion-induced lung injury \[[@CR31]\]. As inhibitor of SRC activation, PP2 can attenuate alveolar macrophage priming for improved lipopolysaccharide responsiveness and induce a modest reduction in lung injury \[[@CR31]-[@CR33]\]. And chemical inhibitors directly or indirectly regulating Src PTKs have been used as potential drugs for the treatment of lung injury \[[@CR34]\]. In the regulatory network of the DEGs, SRC had interaction relationships with PTK2. These declared that SRC might play a role in ALI by mediating PTK2.

Correspondingly, negative regulation of cell proliferation was the most significant biological pathways in GO enrichment analysis. CAV2 is a major component of the inner surface of caveolae. It is involved in essential cellular functions, including signal transduction, lipid metabolism, cellular growth control and apoptosis. Its related family member CAV1 is reported to be a critical regulator of lung injury \[[@CR35]\]. De Almeida *et al.* find that genetic ablation of caveolin-2 sensitizes mice to bleomycin-induced injury \[[@CR36]\]. We speculated that CAV2 might play a role in the pathogenesis of ALI. In the regulatory network of the DEGs, CAV2 were targeted by SRC, indicating that CAV2 might also be involved in ALI by mediating SRC.

To further look into the molecular mechanisms underlying ALI, a gene regulatory network was constructed for the DEGs and various regulatory relationships were visualized. PTK2, SRC and CAV2 are hub genes in the network. As discussed above, these genes are related to cell proliferation. The gene regulatory network further demonstrated the close association between cell growth and ALI.

Conclusion {#Sec13}
==========

Overall, we carried out an integrated bioinformatics analysis of genes which may play a role in ALI. A total of 128 DEGs were identified, including 47 up-regulated genes and 81 down-regulated genes. Functional enrichment analysis showed that cell proliferation and lipid metabolism were closely related to ALI. Moreover, relevant genes like PTK2, SRC and CAV2 might be potential biomarkers for diagnosis and treatment of ALI.
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